This document is an excerpt from the EUR-Lex website
Document E2009G0924(03)
Medicinal products — List of marketing authorisations granted by the EEA EFTA States for the second half of 2008
Medicinal products — List of marketing authorisations granted by the EEA EFTA States for the second half of 2008
Medicinal products — List of marketing authorisations granted by the EEA EFTA States for the second half of 2008
SL C 230, 24.9.2009, p. 18–28
(BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
- Date of document:
- 24/09/2009; Uvodna izjava
- Author:
- Stalni odbor država EFTA-e
- Form:
- Obavijest
- Treaty:
- Ugovor o osnivanju Europske zajednice
- Legal basis:
- Link
- Link
- Link
- Select all documents mentioning this document
- Link
- EUROVOC descriptor:
- Subject matter:
- Directory code:
|
24.9.2009 |
EN |
Official Journal of the European Union |
C 230/18 |
Medicinal products — List of marketing authorisations granted by the EEA EFTA States for the second half of 2008
2009/C 230/08
Subcommittee I on the free movement of goods
To be noted by the EEA Joint Committee
With reference to EEA Joint Committee Decision No 74/1999 of 28 May 1999, the EEA Joint Committee is invited to note the following lists concerning marketing authorisations for medicinal products for the period 1 July-31 December 2008, at their meeting on 24 April 2009:
|
Annex I |
List of new marketing authorisations |
|
Annex II |
List of renewed marketing authorisations |
|
Annex III |
List of extended marketing authorisations |
|
Annex IV |
List of withdrawn marketing authorisations |
|
Annex V |
List of suspended marketing authorisations |
ANNEX I
List of new marketing authorisations
The following marketing authorisations have been granted in the EEA EFTA States during the period 1 July-31 December 2008:
|
EU-Number |
Product |
Country |
Date of authorisation |
|
EU/1/06/380/001 |
Prezista |
Liechtenstein |
31.12.2008 |
|
EU/1/08/444/001/NO-008/NO |
Ratiograstim |
Norway |
2.10.2008 |
|
EU/1/08/444/001-008 |
Ratiograstim |
Liechtenstein |
31.10.2008 |
|
EU/1/08/444/001-008/IS |
Ratiograstim |
Iceland |
24.10.2008 |
|
EU/1/08/445/001/NO-008/NO |
Tevagrastim |
Norway |
8.10.2008 |
|
EU/1/08/445/001-008 |
Tevagrastim |
Liechtenstein |
31.10.2008 |
|
EU/1/08/445/001-008/IS |
Tevagrastim |
Iceland |
24.10.2008 |
|
EU/1/08/446/001/NO-002/NO |
Bridion |
Norway |
12.9.2008 |
|
EU/1/08/449/001/NO-008/NO |
Filgrastim |
Norway |
8.10.2008 |
|
EU/1/08/449/001-008 |
Filgrastim Ratiopharm |
Liechtenstein |
31.10.2008 |
|
EU/1/08/449/001-008/IS |
Filgrastim Ratiopharm |
Iceland |
24.10.2008 |
|
EU/1/08/450/001/NO-008/NO |
Biograstim |
Norway |
2.10.2008 |
|
EU/1/08/450/001-008 |
Biograstim |
Liechtenstein |
31.10.2008 |
|
EU/1/08/450/001-008/IS |
Biograstim |
Iceland |
24.10.2008 |
|
EU/1/08/452/001/NO |
Pandemrix |
Norway |
6.8.2008 |
|
EU/1/08/453/001/NO |
Prepandemrix |
Norway |
18.9.2008 |
|
EU/1/08/455/001/NO-014/NO |
Janumet |
Norway |
5.8.2008 |
|
EU/1/08/455/001-014 |
Janumet |
Liechtenstein |
31.8.2008 |
|
EU/1/08/455/001-014/IS |
Janumet |
Iceland |
5.9.2008 |
|
EU/1/08/456/001/NO-014/NO |
Velmetia |
Norway |
5.8.2008 |
|
EU/1/08/456/001-014 |
Velmetia |
Liechtenstein |
31.8.2008 |
|
EU/1/08/456/001-014/IS |
Velmetia |
Iceland |
5.9.2008 |
|
EU/1/08/457/001/NO-014/NO |
Efficib |
Norway |
5.8.2008 |
|
EU/1/08/457/001-014 |
Efficib |
Liechtenstein |
31.8.2008 |
|
EU/1/08/457/001-014/IS |
Efficib |
Iceland |
5.9.2008 |
|
EU/1/08/458/001/NO-011/NO |
Trevaclyn |
Norway |
29.7.2008 |
|
EU/1/08/458/001-011 |
Trevaclyn |
Liechtenstein |
31.8.2008 |
|
EU/1/08/458/001-011/IS |
Trevaclyn |
Iceland |
25.7.2008 |
|
EU/1/08/459/001/NO-011/NO |
Tredaptive |
Norway |
29.7.2008 |
|
EU/1/08/459/001-011 |
Tredaptive |
Liechtenstein |
31.8.2008 |
|
EU/1/08/459/001-011/IS |
Tredaptive |
Iceland |
25.7.2008 |
|
EU/1/08/460/001/NO-011/NO |
Pelzont |
Norway |
29.7.2008 |
|
EU/1/08/460/001-011 |
Pelzont |
Liechtenstein |
31.8.2008 |
|
EU/1/08/460/001-011/IS |
Pelzont |
Iceland |
25.7.2008 |
|
EU/1/08/461/001 |
Firazyr (orphan drug) |
Liechtenstein |
31.8.2008 |
|
EU/1/08/461/001/IS |
Firazyr |
Iceland |
25.7.2008 |
|
EU/1/08/461/001/NO |
Firazyr |
Norway |
25.8.2008 |
|
EU/1/08/462/001-006/IS |
Latixa |
Iceland |
28.7.2008 |
|
EU/1/08/463/001/NO-003/NO |
Relistor |
Norway |
11.7.2008 |
|
EU/1/08/463/001-003 |
Relistor |
Liechtenstein |
31.8.2008 |
|
EU/1/08/463/001-003/IS |
Relistor |
Iceland |
24.7.2008 |
|
EU/1/08/464/001/NO-017/NO |
Clopidogrel BMS |
Norway |
7.8.2008 |
|
EU/1/08/464/001-017 |
Clopidogrel BMS |
Liechtenstein |
31.8.2008 |
|
EU/1/08/464/001-017/IS |
Clopidogrel BMS |
Iceland |
22.9.2008 |
|
EU/1/08/465/001/NO-017/NO |
Clopidogrel Winthrop |
Norway |
7.8.2008 |
|
EU/1/08/465/001-017 |
Clopidogrel Winthrop |
Liechtenstein |
31.8.2008 |
|
EU/1/08/465/001-017/IS |
Clopidogrel Winthrop |
Iceland |
12.9.2008 |
|
EU/1/08/466/001-002 |
Bridion |
Liechtenstein |
31.8.2008 |
|
EU/1/08/466/001-002/IS |
Bridion |
Iceland |
4.9.2008 |
|
EU/1/08/467/001 |
Doribax |
Liechtenstein |
31.8.2008 |
|
EU/1/08/467/001/IS |
Doribax |
Iceland |
8.9.2008 |
|
EU/1/08/467/001/NO |
Doribax |
Norway |
1.9.2008 |
|
EU/1/08/468/001 |
Intelence |
Liechtenstein |
31.10.2008 |
|
EU/1/08/468/001/IS |
Intelence |
Iceland |
26.9.2008 |
|
EU/1/08/468/001/NO |
Intelence |
Norway |
18.9.2008 |
|
EU/1/08/468/001/NO-025/NO |
Oprymea |
Norway |
9.10.2008 |
|
EU/1/08/469/001-025 |
Oprymea |
Liechtenstein |
31.10.2008 |
|
EU/1/08/469/001-025/IS |
Oprymea |
Iceland |
27.10.2008 |
|
EU/1/08/470/001/NO-016/NO |
Vimpat |
Norway |
22.9.2008 |
|
EU/1/08/470/001-015/IS |
Vimpat |
Iceland |
10.9.2008 |
|
EU/1/08/470/001-016 |
Vimpat |
Liechtenstein |
31.10.2008 |
|
EU/1/08/471/001/NO-012/NO |
Duloxetine Boehringer Ingelheim |
Norway |
29.10.2008 |
|
EU/1/08/471/001-012 |
Duloxetine Boehringer Ingelheim |
Liechtenstein |
31.10.2008 |
|
EU/1/08/471/001-012/IS |
Duloxetine Boehringer Ingelheim |
Iceland |
7.11.2008 |
|
EU/1/08/472/001/NO-008/NO |
Xarelto |
Norway |
9.10.2008 |
|
EU/1/08/472/001-008 |
Xarelto |
Liechtenstein |
31.10.2008 |
|
EU/1/08/472/001-008/IS |
Xarelto |
Iceland |
15.10.2008 |
|
EU/1/08/473/001/NO-003/NO |
Evicel |
Norway |
28.10.2008 |
|
EU/1/08/473/001-003 |
Evicel |
Liechtenstein |
31.10.2008 |
|
EU/1/08/473/001-003/IS |
Evicel |
Iceland |
17.11.2008 |
|
EU/1/08/474/001-003 |
Fluticasone furoate GSK |
Liechtenstein |
31.10.2008 |
|
EU/1/08/475/001/NO-034/NO |
Olanzapine Mylan |
Norway |
29.10.2008 |
|
EU/1/08/475/001-034 |
Olanzapine Mylan |
Liechtenstein |
31.10.2008 |
|
EU/1/08/475/001-034/IS |
Olanzapine Mylan |
Iceland |
21.11.2008 |
|
EU/1/08/476/001/NO-004/NO |
Tadalafil |
Norway |
23.10.2008 |
|
EU/1/08/476/001-004 |
Tadalafil Lilly |
Liechtenstein |
31.10.2008 |
|
EU/1/08/477/001 |
Ceplene (orphan) |
Liechtenstein |
31.10.2008 |
|
EU/1/08/477/001/IS |
Ceplene |
Iceland |
19.11.2008 |
|
EU/1/08/478/001 |
Prepandemic influenza vaccine (H5N1) |
Liechtenstein |
31.10.2008 |
|
EU/1/08/478/001/IS |
Prepandemic influenza vaccine (H5N1) |
Iceland |
24.10.2008 |
|
EU/1/08/478/001/NO |
Prepandemic influenza vaccine |
Norway |
4.12.2008 |
|
EU/1/08/479/001/NO-003/NO |
Zypadhera |
Norway |
16.12.2008 |
|
EU/1/08/479/001-003 |
Zypadhera |
Liechtenstein |
31.12.2008 |
|
EU/1/08/479/001-003/IS |
Zypadhera |
Iceland |
16.12.2008 |
|
EU/1/08/480/001-018 |
Irbesartan Krka |
Liechtenstein |
31.12.2008 |
|
EU/1/08/481/001-003 |
Kuvan (orphan drug) |
Liechtenstein |
31.12.2008 |
|
EU/1/08/482/001-002 |
Azarga |
Liechtenstein |
31.12.2008 |
|
EU/1/08/483/001-018 |
Zomarist |
Liechtenstein |
31.12.2008 |
|
EU/1/08/484/001-018 |
Vildagliptin |
Liechtenstein |
31.12.2008 |
|
EU/1/08/485/001/NO-011/NO |
Jalra |
Norway |
4.12.2008 |
|
EU/1/08/485/001-011 |
Jalra |
Liechtenstein |
31.12.2008 |
|
EU/1/08/485/001-011/IS |
Jalra |
Iceland |
16.12.2008 |
|
EU/1/08/486/001/NO-011/NO |
Xiliarx |
Norway |
4.12.2008 |
|
EU/1/08/486/001-011 |
Xiliarx |
Liechtenstein |
31.12.2008 |
|
EU/1/08/486/001-011/IS |
Xiliarx |
Iceland |
16.12.2008 |
|
EU/1/08477/001/NO |
Ceplene |
Norway |
28.10.2008 |
|
EU/2/08/080/001-004 |
Reconcile |
Liechtenstein |
31.8.2008 |
|
EU/2/08/080/001-004/IS |
Reconcile |
Iceland |
5.8.2008 |
|
EU/2/08/081/001-003/IS |
Posatex |
Iceland |
10.9.2008 |
|
EU/2/08/082/001-003 |
Zactran |
Liechtenstein |
31.8.2008 |
|
EU/2/08/082/001-003/IS |
Zactran |
Iceland |
8.9.2008 |
|
EU/2/08/083/001 |
Equioxx |
Liechtenstein |
31.8.2008 |
|
EU/2/08/084/001/NO-005/NO |
Trocoxil |
Norway |
15.10.2008 |
|
EU/2/08/084/001-005 |
Trocoxil |
Liechtenstein |
31.10.2008 |
|
EU/2/08/084/001-005/IS |
Trocoxil |
Iceland |
24.10.2008 |
|
EU/2/08/085/001 |
Easotic |
Liechtenstein |
31.12.2008 |
|
EU/2/08/086/001/NO-003/NO |
Duvaxyn WNV |
Norway |
18.12.2008 |
|
EU/2/08/086/001-003 |
Duvaxyn WNV |
Liechtenstein |
31.12.2008 |
|
EU/2/08/087/001-002 |
Masivet |
Liechtenstein |
31.12.2008 |
|
EU/2/08/087/001-002/IS |
Masivet |
Iceland |
12.12.2008 |
|
EU/2/08/088/001-004 |
Acticam |
Liechtenstein |
31.12.2008 |
ANNEX II
List of renewed marketing authorisations
The following marketing authorisations have been renewed in the EEA EFTA States during the period 1 July-31 December 2008:
|
EU-Number |
Product |
Country |
Date of authorisation |
|
EU/1/00/162/003/NO-005/NO; EU/1/00/162/009/NO-011/NO; EU/1/00/162/015/NO-017/NO; EU/1/00/162/019/NO-021/NO |
Prandin |
Norway |
15.8.2008 |
|
EU/1/00/162/003-005, 009-011, 015-017, 019-021 |
Prandin |
Liechtenstein |
31.8.2008 |
|
EU/1/00/162/003-005, 009-011, 015-017, 019-021/IS |
Prandin |
Iceland |
26.9.2008 |
|
EU/1/03/247/001/NO-002/NO |
Forsteo |
Norway |
1.7.2008 |
|
EU/1/03/252/001/NO-003/NO |
Fuzeon |
Norway |
12.8.2008 |
|
EU/1/03/252/001-003 |
Fuzeon |
Liechtenstein |
31.8.2008 |
|
EU/1/03/252/001-003/IS |
Fuzeon |
Iceland |
5.8.2008 |
|
EU/1/03/254/002 |
Busilvex |
Liechtenstein |
31.8.2008 |
|
EU/1/03/254/002/IS |
Busilvex |
Iceland |
10.7.2008 |
|
EU/1/03/254/002/NO |
Busilvex |
Norway |
12.8.2008 |
|
EU/1/03/255/001/NO-006/NO |
Ventavis |
Norway |
29.9.2008 |
|
EU/1/03/255/001-006 |
Ventavis |
Liechtenstein |
31.10.2008 |
|
EU/1/03/255/001-006/IS |
Ventavis |
Iceland |
19.10.2008 |
|
EU/1/03/256/001/NO-010/NO |
Humira |
Norway |
25.9.2008 |
|
EU/1/03/256/001-010 |
Humira |
Liechtenstein |
31.10.2008 |
|
EU/1/03/256/001-010/IS |
Humira |
Iceland |
24.10.2008 |
|
EU/1/03/258/001/NO-022/NO |
Avandamet |
Norway |
9.9.2008 |
|
EU/1/03/258/001-022 |
Avandamet |
Liechtenstein |
31.8.2008 |
|
EU/1/03/258/001-022/IS |
Avandamet |
Iceland |
20.10.2008 |
|
EU/1/03/259/001/NO-006/NO |
Onsenal |
Norway |
6.11.2008 |
|
EU/1/03/259/001-006 |
Onsenal |
Liechtenstein |
31.10.2008 |
|
EU/1/03/259/001-006/IS |
Onsenal |
Iceland |
12.12.2008 |
|
EU/1/03/260/001/NO-023/NO |
Stalevo |
Norway |
9.10.2008 |
|
EU/1/03/260/001-023 |
Stalevo |
Liechtenstein |
31.10.2008 |
|
EU/1/03/260/001-023/IS |
Stalevo |
Iceland |
22.10.2008 |
|
EU/1/03/261/001/NO-003/NO |
Emtriva |
Norway |
10.11.2008 |
|
EU/1/03/261/001-003 |
Emtriva |
Liechtenstein |
31.10.2008 |
|
EU/1/03/261/001-003/IS |
Emtriva |
Iceland |
27.10.2008 |
|
EU/1/03/262/001/NO-008/NO |
Emend |
Norway |
8.10.2008 |
|
EU/1/03/262/001-008 |
Emend |
Liechtenstein |
31.10.2008 |
|
EU/1/03/262/001-008/IS |
Emend |
Iceland |
27.10.2008 |
|
EU/1/03/269/001 |
Faslodex |
Liechtenstein |
31.12.2008 |
|
EU/1/06/367/001-012 |
Diacomit |
Liechtenstein |
31.12.2008 |
|
EU/1/06/367/001-012/IS |
Diacomit |
Iceland |
18.12.2008 |
|
EU/1/07/436/001-002 |
Isentress |
Liechtenstein |
31.12.2008 |
|
EU/1/07/436/001-002/IS |
Isentress |
Iceland |
18.12.2008 |
|
EU/1/98/064/001 |
Pylobactell |
Liechtenstein |
31.8.2008 |
|
EU/1/98/064/001/IS |
Pylobactell |
Iceland |
19.10.2008 |
|
EU/1/98/064/001/NO |
Pylobactell |
Norway |
8.12.2008 |
|
EU/1/98/065/001/NO-002/NO |
Optison |
Norway |
18.9.2008 |
|
EU/1/98/065/001-002/IS |
Optison |
Iceland |
10.7.2008 |
|
EU/1/98/069/001a/NO-007a/NO; EU/1/98/069/001b/NO-007b/NO EU/1/98/069/008/NO-010/NO |
Plavix |
Norway |
2.7.2008 |
|
EU/1/98/070/001a/NO-007a/NO; EU/1/98/070/001b/NO-007b/NO; EU/1/98/070/008/NO-010/NO |
Iscover |
Norway |
2.7.2008 |
|
EU/1/98/071/001/NO-006/NO |
Xenical |
Norway |
9.9.2008 |
|
EU/1/98/071/001-006/IS |
Xenical |
Iceland |
10.7.2008 |
|
EU/1/98/073/001/NO-004/NO |
Evista |
Norway |
19.9.2008 |
|
EU/1/98/073/001-004 |
Evista |
Liechtenstein |
31.8.2008 |
|
EU/1/98/073/001-004/IS |
Evista |
Iceland |
22.10.2008 |
|
EU/1/98/074/001/NO-004/NO |
Optruma |
Norway |
19.9.2008 |
|
EU/1/98/074/001-004 |
Optruma |
Liechtenstein |
31.8.2008 |
|
EU/1/98/074/001-004/IS |
Optruma |
Iceland |
22.10.2008 |
|
EU/1/98/076/004/NO-006/NO, EU/1/98/076/011/NO-013/NO, EU/1/98/076/018/NO-020/NO, EU/1/98/076/022/NO-024/NO |
NovoNorm |
Norway |
15.8.2008 |
|
EU/1/98/076/004-006, 011-013, 018-020, 022-024 |
NovoNorm |
Liechtenstein |
31.8.2008 |
|
EU/1/98/076/004-006, 011-013, 018-020, 022-024/IS |
NovoNorm |
Iceland |
25.9.2008 |
|
EU/1/98/077/002/NO-004/NO; EU/1/98/077/006/NO-008/NO; EU/1/98/077/010/NO-019/NO |
Viagra |
Norway |
24.9.2008 |
|
EU/1/98/077/002-004, 006-008, 010-019/IS |
Viagra |
Iceland |
25.10.2008 |
|
EU/1/98/080/001 |
Aldara |
Liechtenstein |
31.10.2008 |
|
EU/1/98/080/001/IS |
Aldara |
Iceland |
19.11.2008 |
|
EU/1/98/080/001/NO |
Aldara |
Norway |
9.10.2008 |
|
EU/1/98/081/001/NO-004/NO |
Comtan |
Norway |
29.9.2008 |
|
EU/1/98/081/001-004 |
Comtan |
Liechtenstein |
31.10.2008 |
|
EU/1/98/081/001-004/IS |
Comtan |
Iceland |
21.10.2008 |
|
EU/1/98/082/001/NO-003/NO; EU/1/98/082/005/NO |
Comtess |
Norway |
29.9.2008 |
|
EU/1/98/082/001-003, 005 |
Comtess |
Liechtenstein |
31.10.2008 |
|
EU/1/98/082/001-003, 005/IS |
Comtess |
Iceland |
21.10.2008 |
|
EU/1/98/084/001/NO-002/NO |
Simulect |
Norway |
11.11.2008 |
|
EU/1/98/084/001-002 |
Simulect |
Liechtenstein |
31.10.2008 |
|
EU/1/98/084/001-002/IS |
Simulect |
Iceland |
7.11.2008 |
|
EU/1/98/085/001/NO-034/NO |
Karvezide |
Norway |
28.10.2008 |
|
EU/1/98/085/001-034 |
Karvezide |
Liechtenstein |
31.12.2008 |
|
EU/1/98/085/001-034/IS |
Karvezide |
Iceland |
28.10.2008 |
|
EU/1/98/086/001/NO-034/NO |
CoAprovel |
Norway |
28.10.2008 |
|
EU/1/98/086/001-034 |
CoAprovel |
Liechtenstein |
31.12.2008 |
|
EU/1/98/086/001-034/IS |
CoAprovel |
Iceland |
28.10.2008 |
|
EU/1/98/089/001-022 |
Pritor |
Liechtenstein |
31.12.2008 |
|
EU/1/98/089/001-022/IS |
Pritor |
Iceland |
18.12.2008 |
|
EU/1/98/090/001-020 |
Micardis |
Liechtenstein |
31.12.2008 |
|
EU/1/98/090/001-020/IS |
Micardis |
Iceland |
18.12.2008 |
|
EU/1/98/091/001-014 |
Kinzalmono |
Liechtenstein |
31.12.2008 |
|
EU/1/98/091/001-014/IS |
Kinzalmono |
Iceland |
18.12.2008 |
|
EU/2/03/040/001-002/IS |
Gonazon |
Iceland |
11.7.2008 |
|
EU/2/03/041/001-005 |
Draxxin |
Liechtenstein |
31.10.2008 |
|
EU/2/03/041/001-005/IS |
Draxxin |
Iceland |
27.10.2008 |
|
EU/2/98/009/001/NO-006/NO |
Suvaxyn Aujeszky |
Norway |
18.12.2008 |
|
EU/2/98/009/001-006 |
Suvaxyn Aujeszky |
Liechtenstein |
31.10.2008 |
|
EU/2/99/011/001 |
Locatim |
Liechtenstein |
31.12.2008 |
ANNEX III
List of extended marketing authorisations
The following marketing authorisations have been extended in the EEA EFTA States during the period 1 July-31 December 2008:
|
EU-Number |
Product |
Country |
Date of authorisation |
|
EU/1/01/183/030-032 |
HBVAXPRO |
Liechtenstein |
31.10.2008 |
|
EU/1/01/195/022-027 |
Liprolog |
Liechtenstein |
31.8.2008 |
|
EU/1/01/195/022-027/IS |
Liprolog |
Iceland |
11.8.2008 |
|
EU/1/02/214/011/NO-015/NO |
Kinzalkomb |
Norway |
15.9.2008 |
|
EU/1/02/215/015/NO-021/NO |
PritorPlus |
Norway |
15.9.2008 |
|
EU/1/03/255/006 |
Ventavis |
Liechtenstein |
31.8.2008 |
|
EU/1/03/267/010 |
Reyataz |
Liechtenstein |
31.12.2008 |
|
EU/1/04/291/003 |
Raptiva |
Liechtenstein |
31.10.2008 |
|
EU/1/04/291/003/NO |
Raptiva |
Norway |
26.11.2008 |
|
EU/1/04/305/002 |
Truvada |
Liechtenstein |
31.10.2008 |
|
EU/1/04/305/002/NO |
Truvada |
Norway |
16.9.2008 |
|
EU/1/05/330/005/NO-011/NO |
Rotarix |
Norway |
6.10.2008 |
|
EU/1/05/330/005-011 |
Rotarix |
Liechtenstein |
31.10.2008 |
|
EU/1/05/330/005-011/IS |
Rotarix |
Iceland |
27.9.2008 |
|
EU/1/05/331/038/NO-055/NO |
Neupro |
Norway |
25.9.2008 |
|
EU/1/05/331/038-055 |
Neupro |
Liechtenstein |
31.10.2008 |
|
EU/1/05/331/038-055/IS |
Neupro |
Iceland |
15.10.2008 |
|
EU/1/06/343/006-007 |
Baraclude |
Liechtenstein |
31.8.2008 |
|
EU/1/06/356/007-009 |
Exjade |
Liechtenstein |
31.12.2008 |
|
EU/1/06/360/012 |
Champix |
Liechtenstein |
31.8.2008 |
|
EU/1/06/368/088/NO-142/NO |
Insulin Human Winthrop |
Norway |
28.11.2008 |
|
EU/1/06/368/088-142 |
Insulin Human Winthrop |
Liechtenstein |
31.12.2008 |
|
EU/1/07/386/011-012 |
Toviaz |
Liechtenstein |
31.8.2008 |
|
EU/1/07/386/013-016 |
Toviaz |
Liechtenstein |
31.12.2008 |
|
EU/1/07/392/002 |
Circadin |
Liechtenstein |
31.8.2008 |
|
EU/1/07/394/007-009 |
Optaflu |
Liechtenstein |
31.8.2008 |
|
EU/1/07/400/017/NO-021/NO |
Mircera |
Norway |
13.10.2008 |
|
EU/1/07/400/017-020/IS |
Mircera |
Iceland |
17.10.2008 |
|
EU/1/07/400/017-021 |
Mircera |
Liechtenstein |
31.10.2008 |
|
EU/1/07/410/017-020 |
Binocrit |
Liechtenstein |
31.8.2008 |
|
EU/1/07/411/017-020 |
Epoetin alfa Hexal |
Liechtenstein |
31.8.2008 |
|
EU/1/07/412/017-020 |
Abseamed |
Liechtenstein |
31.8.2008 |
|
EU/1/07/414/018 |
Galvus |
Liechtenstein |
31.10.2008 |
|
EU/1/07/419/010-012 |
Cervarix |
Liechtenstein |
31.12.2008 |
|
EU/1/07/431/020/NO-025/NO |
Retacrit |
Norway |
15.12.2008 |
|
EU/1/07/431/020-025 |
Retacrit |
Liechtenstein |
31.12.2008 |
|
EU/1/07/432/020-022 |
Silapo |
Liechtenstein |
31.8.2008 |
|
EU/1/95/003/007/NO-008/NO |
Betaferon |
Norway |
13.11.2008 |
|
EU/1/95/003/007-008 |
Betaferon |
Liechtenstein |
31.12.2008 |
|
EU/1/97/030/140/NO-169/NO |
Insuman |
Norway |
1.12.2008 |
|
EU/1/97/030/140-169 |
Insuman |
Liechtenstein |
31.12.2008 |
|
EU/102/206/021/NO-035/NO |
Arixtra |
Norway |
8.9.2008 |
|
EU/102/206/021-035 |
Arixtra |
Liechtenstein |
31.10.2008 |
|
EU/2/02/033/002 |
Dexdomitor |
Liechtenstein |
31.8.2008 |
|
EU/2/05/054/018/NO-031/NO |
Profender |
Norway |
24.9.2008 |
|
EU/2/05/054/018-031 |
Profender |
Liechtenstein |
31.10.2008 |
|
EU/2/05/054/018-031/IS |
Profender |
Iceland |
1.10.2008 |
|
EU/2/06/058/004 |
Flexicam |
Liechtenstein |
31.12.2008 |
|
EU/2/99/015/002 |
Oxyglobin |
Liechtenstein |
31.10.2008 |
ANNEX IV
List of withdrawn marketing authorisations
The following marketing authorisations have been withdrawn in the EEA EFTA States during the period 1 July-31 December 2008:
|
EU-Number |
Product |
Country |
Date of withdrawal |
|
EU/1/01/184/001-073 |
Nespo |
Liechtenstein |
31.12.2008 |
|
EU/1/01/185/023-030 |
Aranesp |
Liechtenstein |
31.12.2008 |
|
EU/1/02/202/001-006 |
Protopy |
Liechtenstein |
31.10.2008 |
|
EU/1/02/202/001-006/IS |
Protopy |
Iceland |
27.9.2008 |
|
EU/1/02/228/001-003 |
Neupopeg |
Liechtenstein |
31.12.2008 |
|
EU/1/04/293/001-012 |
Parareg |
Liechtenstein |
31.12.2008 |
|
EU/1/04/301/001/NO-005/NO |
Quintanrix |
Norway |
25.11.2008 |
|
EU/1/04/301/001-005 |
Quintanrix |
Liechtenstein |
31.10.2008 |
|
EU/1/04/301/001-005/IS |
Quintanrix |
Iceland |
27.9.2008 |
|
EU/1/05/327/001/NO-018/NO |
Exubera |
Norway |
25.11.2008 |
|
EU/1/05/327/001-018 |
Exubera |
Liechtenstein |
31.10.2008 |
|
EU/1/05/327/001-018/IS |
Exubera |
Iceland |
22.10.2008 |
|
EU/1/98/093/002 |
Forcaltonin |
Liechtenstein |
31.12.2008 |
|
EU/1/98/093/002/IS |
Forcaltonin |
Iceland |
29.11.2008 |
|
EU/1/98/093/002/NO |
Forcaltonin |
Norway |
25.11.2008 |
|
EU/1/99/128/001/NO-037/NO |
Viraferon |
Norway |
29.10.2008 |
|
EU/1/99/128/001-037 |
Viraferon |
Liechtenstein |
31.10.2008 |
|
EU/1/99/128/001-037/IS |
Viraferon |
Iceland |
22.10.2008 |
ANNEX V
List of suspended marketing authorisations
The following marketing authorisations have been suspended in the EEA EFTA States during the period 1 July-31 December 2008:
|
EU-Number |
Product |
Country |
Date of suspension |
|
EU/1/06/344/001-011 |
Acomplia |
Liechtenstein |
31.12.2008 |
|
EU/1/06/344/001-011/IS |
Acomplia |
Iceland |
26.11.2008 |
|
EU/1/06/345/001-011 |
Zimulti |
Liechtenstein |
31.12.2008 |
|
EU/1/06/345/001-011/IS |
Zimulti |
Iceland |
26.11.2008 |
